CHICAGO — U.S. biotech firm Moderna’s coronavirus vaccine has successfully triggered an immune response in all volunteers against COVID-19 during preliminary testing, according to a study in the New England Journal of Medicine. SOURCES: The New England Journal of Medicine,…
Tag